Insider filing · GLUE
Filip Janku
Chief Medical Officer
profile →
Monte Rosa Therapeutics, Inc.
GLUE · Healthcare · 15 filings in 24 months
ticker →
Filip Janku sold $882K of Monte Rosa Therapeutics (GLUE)
Executed Jun 23, disclosed Jun 25, 2 days later.
Value, as filed
$882K
41,845 sh across 2 lots
Executed
Jun 23
the trade date, as filed
Disclosed
Jun 25
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
FJFilip Janku (Chief Medical Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Monte Rosa Therapeutics, Inc. (GLUE). The largest single filing was $882K of GLUE (41,845 sh across 2 lots, as filed), executed Jun 23.
The name
GLUEHealthcare · Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicin…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Filip Janku in GLUE
GLUESALE
Monte Rosa Therapeutics, Inc.
$132K5,407 sh × $24.50
Exec Jun 30
Filed Jul 1 · 4:57 PM ET GLUESALE Monte Rosa Therapeutics, Inc. $138K
6,000 sh × $22.95
Exec Jun 29
Filed Jun 30 · 5:30 PM ET GLUESALE Monte Rosa Therapeutics, Inc. $179K
9,189 sh × $19.50
Exec Feb 23
Filed Feb 24 · 5:30 PM ET